Unison Metals Announces 10:1 Stock Split and Thyrocare Technologies Plans 2:1 Bonus Issue for November 2025

As November draws to a close, two significant corporate actions are poised to stir market interest. A 2:1 bonus issue and a 10:1 stock split by two well-known companies are expected to create a buzz among investors. Let's delve into these stocks and understand why they are garnering attention.

Unison Metals is implementing a stock split, reducing its face value from Rs.10 to Rs.1, effectively creating a 10:1 stock split. The record and ex-date for this action is set for 28 November 2025. This move is anticipated to increase liquidity and attract more investors.

A R Ramachandran, an Independent SEBI registered Research Analyst at Tips2trades, commented on Unison Metals' stock performance. "Unison Metals stock price is bearish on the Daily charts with strong resistance at 22.65. A Daily close below support of 19 could lead to a target of 17.6 in the near term," he noted.

Thyrocare Technologies is planning a bonus issue with a ratio of 2:1, meaning shareholders will receive two additional shares for every one they hold. The record and ex-date for this bonus issue are also scheduled for 28 November 2025. This action aims to reward existing shareholders and potentially enhance the stock's appeal.

Regarding Thyrocare Technologies, A R Ramachandran provided his analysis: "Thyrocare stock price is bearish on the Daily charts with strong resistance at 1526. A Daily close below support of 1450 could lead to a target of 1313 in the near term," he stated.

Both companies' actions are set against the backdrop of market anticipation as investors watch closely for potential opportunities. These corporate strategies might influence trading volumes and investor sentiment in the coming days.

The opinions and recommendations shared here are those of individual analysts or entities and do not represent the views of Goodreturns.in or Greynium Information Technologies Private Limited. We do not vouch for the accuracy or reliability of any content provided here, nor do we offer investment advice or solicit securities transactions. All information should be independently verified with licensed financial advisors before making any investment decisions.